Jobbé-Duval, A.; Bochaton, T.; Baudry, G.; Bonnefoy-Cudraz, E.; Hugon-Vallet, E.; Pozzi, M.; Obadia, J.-F.; Tomasevic, D.; Amaz, C.; Mewton, N.;
et al. Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients. J. Clin. Med. 2021, 10, 2571.
https://doi.org/10.3390/jcm10122571
AMA Style
Jobbé-Duval A, Bochaton T, Baudry G, Bonnefoy-Cudraz E, Hugon-Vallet E, Pozzi M, Obadia J-F, Tomasevic D, Amaz C, Mewton N,
et al. Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients. Journal of Clinical Medicine. 2021; 10(12):2571.
https://doi.org/10.3390/jcm10122571
Chicago/Turabian Style
Jobbé-Duval, Antoine, Thomas Bochaton, Guillaume Baudry, Eric Bonnefoy-Cudraz, Elisabeth Hugon-Vallet, Matteo Pozzi, Jean-Francois Obadia, Danka Tomasevic, Camille Amaz, Nathan Mewton,
and et al. 2021. "Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients" Journal of Clinical Medicine 10, no. 12: 2571.
https://doi.org/10.3390/jcm10122571
APA Style
Jobbé-Duval, A., Bochaton, T., Baudry, G., Bonnefoy-Cudraz, E., Hugon-Vallet, E., Pozzi, M., Obadia, J.-F., Tomasevic, D., Amaz, C., Mewton, N., & Sebbag, L.
(2021). Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients. Journal of Clinical Medicine, 10(12), 2571.
https://doi.org/10.3390/jcm10122571